Case Reports in Oncological Medicine
Scope & Guideline
Advancing oncology through shared clinical insights.
Introduction
Aims and Scopes
- Clinical Case Reports:
The journal emphasizes detailed clinical case reports that provide insights into unique presentations or rare manifestations of cancers, enhancing the knowledge base of oncologists. - Multidisciplinary Approaches:
It showcases cases involving multidisciplinary treatment strategies, highlighting the importance of collaboration among various specialists in managing complex oncological cases. - Innovative Treatment Strategies:
The journal frequently discusses novel therapies and their outcomes, including the use of targeted therapies, immunotherapies, and other emerging treatment modalities. - Pathological Insights:
Pathological analyses and findings play a crucial role in the reports, often leading to discussions on the implications for diagnosis and prognosis. - Patient-Centered Outcomes:
There is a consistent focus on patient outcomes, including quality of life and treatment efficacy, which are critical for informing future clinical practices.
Trending and Emerging
- Immunotherapy and Checkpoint Inhibitors:
There is a growing number of case reports addressing the effects and complications of immunotherapy, particularly immune checkpoint inhibitors, highlighting their significance in modern cancer treatment. - Genetic and Molecular Insights:
Emerging cases that delve into the genetic and molecular underpinnings of cancers are on the rise, reflecting a shift towards personalized medicine and targeted therapies. - Rare and Uncommon Tumors:
The focus on rare tumor types and unusual presentations is trending, providing critical insights into less understood malignancies and their management. - Multimodal Treatment Approaches:
Increasingly, reports are showcasing combined treatment modalities (e.g., surgery, chemotherapy, and radiotherapy), emphasizing a comprehensive approach to complex oncology cases. - Patient-Specific Treatment Responses:
There is a trend towards documenting individual patient responses to specific treatments, which is vital for understanding the variability of treatment efficacy and guiding future clinical decisions.
Declining or Waning
- Traditional Chemotherapy Case Reports:
There has been a noticeable decline in the publication of case reports solely focusing on traditional chemotherapy regimens, as newer treatment modalities gain traction and become the focus of clinical discussion. - Palliative Care Case Studies:
Fewer case reports are dedicated to palliative care approaches, suggesting a shift towards curative or innovative treatment discussions in oncology. - Basic Science Reports:
Reports that primarily focus on basic science or laboratory findings related to oncology are less common, indicating a preference for clinical applications and case-related insights. - Epidemiological Studies:
There is a decrease in the publication of case reports centered around epidemiological data, possibly as more comprehensive studies and reviews are published elsewhere. - Generalized Cancer Types:
The journal has shifted away from more generalized cancer types, focusing instead on rarer cancers and unique presentations that offer novel insights.
Similar Journals
Molecular and Clinical Oncology
Advancing cancer research for a healthier tomorrow.Molecular and Clinical Oncology is a dynamic journal published by SPANDIDOS PUBL LTD, aimed at advancing the understanding of cancer biology and treatment modalities. With an ISSN of 2049-9450 and an E-ISSN of 2049-9469, the journal serves as a critical platform for researchers and clinicians dedicated to uncovering novel insights in molecular oncology and enhancing clinical practices. As a testament to its growing influence, the journal has achieved a Q3 ranking in Oncology and a Q4 ranking in Cancer Research for the year 2023, reflecting its commitment to publishing high-quality research. Although currently not an Open Access publication, the journal offers crucial subscription options, ensuring comprehensive access to groundbreaking studies and innovations in the field. With converged years spanning 2018 to 2024, the journal is set to continue enriching the academic community with its valuable contributions, ultimately empowering researchers, professionals, and students engaged in the fight against cancer.
Case Reports in Dermatology
Transforming patient outcomes through shared clinical experiences.Case Reports in Dermatology is a leading Open Access academic journal dedicated to the publication of case reports and unique clinical findings in the field of dermatology. Published by KARGER and based in Switzerland, the journal has been an open access resource since 2009, enhancing the visibility and accessibility of vital research for dermatology professionals and the scientific community. With an impressive ISSN of 1662-6567 and ranking in the Q3 category among dermatological journals, it serves as a crucial platform for researchers seeking to share innovative case studies, validate diagnostic approaches, and explore treatment outcomes. The journal continues to contribute to advancing dermatological science with a convergence timeline extending from 2010 to 2024. By promoting the dissemination of emerging knowledge and practices, Case Reports in Dermatology plays a significant role in fostering collaboration among practitioners, enhancing educational efforts, and ultimately improving patient care in dermatology.
SAGE Open Medical Case Reports
Advancing Clinical Understanding One Case at a TimeSAGE Open Medical Case Reports, published by SAGE Publications Inc, is a pioneering open-access journal dedicated to the rapid dissemination of medical case reports that significantly contribute to clinical knowledge and practice. Since its launch in 2013, this journal has become a valuable resource for healthcare professionals, researchers, and students in the field of medicine, facilitating the exchange of unique clinical experiences from around the globe. While the journal is categorized as Q4 in the Medicine (miscellaneous) quartile and holds a Scopus rank of 423 out of 636 in the General Medicine category, the accessibility of its content underscores its commitment to enhancing medical education and informing practice. With no subscription barriers, it supports the sharing of critical insights appropriate to a diverse audience, thereby fostering a culture of innovation and collaboration in healthcare.
International Medical Case Reports Journal
Transforming Clinical Discoveries into Global Knowledge.International Medical Case Reports Journal is a premier open-access publication dedicated to the rapid dissemination of case reports that encompass all fields of medicine. Established by DOVE MEDICAL PRESS LTD in New Zealand, this journal has been contributing to the medical community since 2008, offering a platform for health professionals, researchers, and students to share significant clinical discoveries and insights. With an impact factor reflecting its robust academic influence, the journal has achieved a ranking of #285 out of 636 in the general medicine category on Scopus, placing it in the 55th percentile accordingly. The journal is indexed in various databases, promoting visibility and accessibility to a wide audience, with its Open Access policy ensuring that vital medical knowledge is freely available for all. The International Medical Case Reports Journal plays a crucial role in advancing medical research and education, making it an essential resource for anyone committed to enhancing patient care and clinical practice.
Journal of Kidney Cancer and VHL
Shaping the dialogue on kidney cancer advancements.The Journal of Kidney Cancer and VHL stands as a leading platform for disseminating cutting-edge research in the field of renal oncology, particularly focused on kidney cancer and Von Hippel-Lindau (VHL) disease. Published by CODON PUBLICATIONS since its inception, this Open Access journal, with ready accessibility since 2014, aims to foster knowledge exchange and collaboration among researchers, clinicians, and healthcare professionals dedicated to improving outcomes for patients with kidney cancer. With an ISSN of 2203-5826, this journal serves as a vital resource in the academic community, encouraging submissions that span various topics, including epidemiology, treatment modalities, and innovative therapeutic strategies. By providing unrestricted access to its content, the Journal of Kidney Cancer and VHL promotes inclusive participation in the global dialogue surrounding these critical health challenges, ensuring that the latest findings reach all corners of the scientific community.
Hematology Reports
Fostering collaboration in hematological research.Hematology Reports is an esteemed academic journal in the field of hematology, dedicated to advancing the understanding of blood disorders and their treatment. Published by MDPI, a leading Swiss publisher known for its commitment to open access since 2009, this journal provides a valuable platform for researchers and healthcare professionals to disseminate innovative findings and foster collaboration within the academic community. The journal features an array of articles ranging from clinical studies to laboratory research, and is indexed in Scopus, where it currently holds a rank of 113 out of 137 in the Medicine - Hematology category, placing it in the 17th percentile. As an open-access journal, Hematology Reports ensures that critical research is accessible to a global audience, supporting the dissemination of knowledge that has the potential to improve patient outcomes. This journal is an essential resource for those engaged in the study and treatment of hematological conditions, encouraging dialogue and the exchange of ideas to enhance clinical practices.
Revista Colombiana de Cancerologia
Exploring New Frontiers in OncologyRevista Colombiana de Cancerologia is a premier journal dedicated to advancing the field of oncology in Colombia and beyond. Published by the Instituto Nacional de Cancerología, this journal serves as a vital platform for the dissemination of high-quality research, comprehensive reviews, and innovative methodologies pertinent to cancer research and treatment. With an ISSN of 0123-9015 and E-ISSN 2346-0199, it aims to engage a diverse audience, including researchers, healthcare professionals, and students, fostering collaboration and knowledge sharing within the oncology community. Although specific metrics such as impact factors and H-index are currently unavailable, the journal is committed to maintaining high academic standards and encouraging open access to vital oncological insights. The Revista Colombiana de Cancerologia is positioned as an essential resource for those interested in the latest advancements in cancer care, prevention, and research methodologies, making significant contributions to the understanding and management of cancer.
Rare Tumors
Transforming the landscape of rare tumor research.Rare Tumors, published by SAGE Publications Ltd, is a premier open-access journal dedicated to advancing the understanding and research of rare neoplasms. With the ISSN 2036-3605 and E-ISSN 2036-3613, this journal provides a vital platform for sharing innovative research findings and clinical insights since its inception in 2009. Situated in Italy, Rare Tumors has a converged publication timeline from 2010 to 2024 and aims to foster a supportive community for researchers and professionals in the oncology and histology fields. It has achieved a notable Q3 ranking in Oncology and Q4 in Histology as of 2023, reflecting its crucial role in bridging the knowledge gap in these specialized areas. Despite its relatively humble Scopus ranks, the journal's open-access model ensures that vital information reaches a broad audience, including those in academia, clinical practice, and beyond. It aspires to not only document rare tumor cases but also stimulate dialogue on their diagnosis, treatment, and management strategies, making it an indispensable resource for anyone dedicated to tackling the challenges posed by rare tumors.
BJR Case Reports
Connecting professionals with pioneering case studies.BJR Case Reports is a prominent open access journal published by the British Institute of Radiology, dedicated to advancing the field of radiology through the dissemination of high-quality case reports. Since its establishment in 2016, the journal has aimed to provide a platform for sharing unique clinical findings, innovative techniques, and educational insights that enhance the understanding of imaging and its applications in patient care. With an ISSN of 2055-7159, the journal not only addresses the pressing needs of researchers and healthcare professionals but also nurtures the academic growth of students entering this critical field. Located in London, England, BJR Case Reports fosters a collaborative environment for radiologists worldwide, ensuring that groundbreaking cases are accessible through its open access format. This commitment to sharing knowledge not only elevates the standard of practice but also contributes significantly to the global discourse in radiological sciences.
ACG Case Reports Journal
Empowering Clinicians with Evidence-Based Case StudiesACG Case Reports Journal, published by Lippincott Williams & Wilkins, is a pivotal resource in the realm of gastrointestinal medicine and clinical practice. Since its inception in 2014, this open-access journal has dedicated itself to disseminating high-quality case reports that contribute to the evolving understanding of gastrointestinal diseases and their management. With an impressive ranking of #203 out of 529 in the General Medicine category according to Scopus, placing it in the 61st percentile, the journal underscores its significant role in advancing medical knowledge. This accessibility allows researchers, healthcare professionals, and students to engage with groundbreaking case studies, enriching their expertise and promoting informed clinical decision-making. ACG Case Reports Journal aims to foster a collaborative environment where innovative ideas and clinical experiences converge, ultimately enhancing patient care and outcomes in the field of gastroenterology.